WHO Handbook Aims to Accelerate Global Hepatitis Elimination Efforts
The World Health Organization (WHO) recently launched a consolidated guidance and implementation handbook focused on preventing, testing for, treating, and monitoring hepatitis B and C. This initiative, unveiled on March 16, 2026, brings together a decade of evidence-based recommendations into a single, practical resource for global health professionals.
A Decade of Progress, Consolidated
Marking 10 years since the adoption of WHO’s first Global health sector strategy on viral hepatitis, the handbook is designed to bridge the gap between policy and action. It aims to help countries expand equitable, person-centred hepatitis services across all levels of the health system. The guidance is structured in a modular format, covering key areas like preventing mother-to-child transmission, implementing birth dose vaccination programs, streamlining testing procedures, and establishing robust data monitoring systems.
The Scale of the Challenge
Viral hepatitis remains a significant global health threat. In 2022, diseases related to hepatitis B and C cirrhosis and liver cancer caused 1.3 million deaths – over 3,500 deaths daily. Currently, an estimated 254 million people live with chronic hepatitis B, and 50 million with chronic hepatitis C. Despite the availability of effective prevention tools, like vaccines for hepatitis B, and curative treatments for hepatitis C, many remain undiagnosed and untreated.
Webinar to Detail Implementation Strategies
A webinar is scheduled for Thursday, March 26, 2026, from 12:30–14:00 CET, to provide an overview of the recent guidance. The webinar will be held in English and will focus on translating policy into practical actions, sharing real-world examples of successful hepatitis interventions, and discussing potential solutions to implementation barriers.
Expert Insights and Global Collaboration
The webinar will feature a diverse group of speakers, including Niklas Luhman from the Île-de-France Regional Health Agency, Wendy Spearman from the University of Cape Town, Su Wang from Cooperman Barnabas Medical Center, Dr Mohamed Hassany from the Egyptian Ministry of Health and Population, Dr Rabson Kachala from the Malawian Ministry of Health, Dr Tereza Kasaeva and Olufunmilayo Lesi from the WHO, and representatives from UNITAID, MPP (Medicines Patent Pool), and GAVI. Matteo Zignol from the WHO will moderate the session.
Simplified Treatment and Expanded Access
The WHO guidance emphasizes simplified treatment approaches for hepatitis B and endorses the use of direct-acting antivirals for hepatitis C, offering a curative option for those infected. It likewise promotes decentralized service delivery models, integrating hepatitis services with primary care, HIV, and tuberculosis programs to expand access and improve efficiency.
Future Trends: Towards Hepatitis Elimination
The release of this handbook signals a shift towards more integrated and streamlined approaches to hepatitis care. Several trends are likely to shape the future of hepatitis elimination efforts:
- Point-of-Care Testing: Increased use of rapid and point-of-care testing tools will be crucial for identifying infections, particularly in resource-limited settings.
- Decentralized Treatment: Expanding treatment access beyond traditional hospital settings, integrating it into primary care and community health programs.
- Data-Driven Strategies: Robust data and monitoring systems will be essential for tracking progress, identifying gaps in service delivery, and tailoring interventions to specific populations.
- Task Sharing and Differentiated Care: Training and empowering a wider range of healthcare workers to deliver hepatitis services, and tailoring care pathways to individual patient needs.
- Global Partnerships: Continued collaboration between international organizations, governments, and the private sector will be vital for securing funding, developing new technologies, and scaling up interventions.
Did you recognize? Hepatitis B is preventable through vaccination, making it a prime target for public health interventions.
FAQ
- What is the main goal of the WHO handbook? To provide a practical guide for countries to accelerate progress towards eliminating hepatitis B and C by 2030.
- Who is the handbook intended for? Programme managers, policymakers, clinicians, donors, and partners involved in hepatitis prevention and care.
- What are the key areas covered in the guidance? Prevention, testing, treatment, service delivery, and monitoring.
- Is treatment available for hepatitis B and C? Yes, safe and effective treatments are available for both, including a cure for hepatitis C.
Pro Tip: Early detection and treatment are crucial for preventing the long-term complications of hepatitis B and C, such as liver cirrhosis and liver cancer.
Learn more about global viral hepatitis efforts at the CDC website and the WHO publications portal.
Share your thoughts on the new WHO guidance and the future of hepatitis elimination in the comments below!
